Background-Mildly oxidized LDL (moxLDL) is thought to play a role in atherogenesis. MoxLDL induces derivatization of cell proteins and triggers a variety of intracellular signaling. We aimed to investigate whether moxLDL-induced protein derivatization may influence the activity of platelet-derived growth factor receptor ␤ (PDGFR␤), a tyrosine kinase receptor of major importance in vascular biology and atherogenesis. Methods and Results-In cultured rabbit arterial smooth muscle cells, moxLDL induces activation of the PDGFR␤ signaling pathway, as shown by PDGFR␤ tyrosine phosphorylation on Western blot and coimmunoprecipitation of SH2-containing proteins. The cellular events involved in the moxLDL-induced PDGFR␤ activation can be summarized as follows. Oxidized lipids from moxLDL trigger two phases of PDGFR␤ activation involving two separate mechanisms, as shown by experiments on cultured cells (in situ) and on immunopurified PDGFR␤ (in vitro): (1) the first phase may be mediated by 4-hydroxynonenal, which induces PDGFR␤ adduct formation and subsequent PDGFR␤ activation (antioxidant-insensitive step); (2) the second phase involves ceramide-mediated generation of H 2 O 2 (these steps being inhibited by tosylphenylalanylchloromethylketone, an inhibitor of ceramide formation, and by antioxidant BHT, exogenous catalase, or overexpressed human catalase). Because 4-hydroxynonenal-PDGFR␤ adducts are also detected in atherosclerotic aortas, it is suggested that this novel mechanism of moxLDL-induced PDGFR␤ activation may occur during atherogenesis. Conclusions-MoxLDL acts as a local autoparacrine mediator in the vascular wall, and PDGFR␤ acts as a sensor for both oxidized lipids and oxidative stress. This constitutes a novel mechanism of PDGFR␤ activation in atherosclerotic areas.
A therogenesis involves a complex sequence of events associating endothelial activation, transendothelial migration of mononuclear cells, lipid accumulation, and smooth muscle cell proliferation, leading finally to fibroatheroma plaque formation. 1 LDL is thought to become atherogenic after undergoing oxidative modifications, 2,3 characterized by oxidized lipid formation and structural alterations of apoB. 3, 4 Oxidized LDL (oxLDL) is present in atherosclerotic areas 3 and elicits changes in (1) lipoprotein metabolism (foam cells), (2) gene expression (adhesion molecules, cytokines, growth factors, coagulation proteins), (3) cell migration, motility, and contractility, (4) cell proliferation; (5) cell viability/death, and (6) local immune response. 3 OxLDL triggers or alters various signaling pathways, 5 namely calcium, 6 trimeric G proteins and cAMP, 7 phospholipase D, 8 ceramide, 9 PPAR␥, 10 and epidermal growth factor receptor (EGFR activation being associated with 4-hydroxynonenal [4-HNE] derivatization). 11 We have examined whether this concept may be extended to platelet-derived growth factor receptor ␤ (PDGFR␤), a tyrosine kinase receptor of importance in atherogenesis. 12 PDGFR␣ and PDGFR␤ belong to the tyrosine kinase receptor family. PDGFR␤ binds only PDGF B-chain, whereas PDGFR␣ binds A and B PDGF isoforms. [13] [14] [15] PDGFR␣ is involved in smooth muscle cell (SMC) hypertrophy, and PDGFR␤ is involved in the migration and proliferation of SMC, [13] [14] [15] a major event in atherosclerotic plaque formation. 12 PDGFR␤ activation triggers tyrosine phosphorylation, which creates binding sites for SH2-containing proteins, including Src, phospholipase C-␥1, phosphatidylinositol-3Ј-kinase, SHP2 protein tyrosine phosphatase, GTPase-activating protein of p21ras (rasGAP), Nck, Grb2, and Shc. [13] [14] [15] We found that oxidized lipids of mildly oxidized LDL (moxLDL) induce derivatization of PDGFR␤ (among other cell proteins 16 ) and trigger activation of the PDGFR␤ signaling pathway. Two separate mechanisms are involved: a first antioxidant-independent early phase resulting possibly from PDGFR␤ derivatization by 4-HNE and a second antioxidantsensitive phase mediated (at least in part) by ceramide and reactive oxygen species (ROS).
Methods

Cell Culture
Rabbit arterial SMC and SMCcatϩ (transduced with catalase cDNA and overexpressing catalase by 350%) 17 and human ECV-304 EC (from ATCC) and LDL receptor-negative fibroblasts (GM-486A from NIGMD) were grown in RPMI-1640 containing 10% FCS. Subconfluent cells were starved for 24 hours before experiments in 0.5% FCS. 11
Rabbits
New Zealand White male rabbits (2.5 kg) were randomly assigned to regular (nϭ3) and hypercholesterolemic (1% cholesterol for 8 weeks) (nϭ8) diets. After euthanasia (pentobarbital 50 mg/kg), thoracic aortas were removed and fatty streaks were stained with Sudan IV. Experiments were performed according to French Accreditation of Laboratory Animal Care.
LDL and Lipids
Human LDL was oxidized by UV-C irradiation (moxLDL) 18 or by overnight incubation with ECV-304 EC (cell-moxLDL). 9 MoxLDL contained 3.2 to 4.9 nmol TBARS and 6.5 to 8.7 nmol 4-HNE/mg apoB) and minor apoB alterations (TNBS-reactive amino groups were 89% to 95% of nonoxidized LDL; relative electrophoretic mobility ranged between 1.1 and 1.3).
[ 3 H]4-HNE was prepared from [ 3 H]4-HNE diethylacetal (a generous gift of J.P. Cravedi, Toulouse) 19 and allowed to react with moxLDL for 1 hour. Cells (4 culture flasks of 80 cm 2 , containing 1.5 mg cell protein) were preincubated with inhibitors, incubated with [ 3 H]4-HNE-moxLDL (250 000 dpm/100 g apoB/mL for 1 hour), washed, harvested, and used for PDGFR␤ immunoprecipitation and counting the PDGFR␤-associated radioactivity.
Sphingomyelinase (Smase) treatment of LDL was performed with B cereus Smase (Sigma) (40 mU/mL, 1 hour, 37°C in 5 mmol/L MgCl 2 , 0.1 mol/L tris/HCl, pH 7.5); Smase-treated LDL was separated from sphingomyelinase on a Sephadex G75 column (Pharmacia). Lipids were extracted in chloroform/methanol by the Folch procedure, as previously used. 11
Western Blot Analysis
Cells or tissue samples were lysed, PDGFR␤ was immunoprecipitated, and Western blots were performed as reported. 11
Determination of PDGFR␤-Free Amino Groups
The free amino group content of PDGFR␤ was evaluated after immunoprecipitation by [ 
Intracellular ROS Determination
Intracellular ROS were determined fluorometrically with the use of dichlorodihydrofluorescein diacetate (H2DCFDA) or dihydrorhodamine (DHR) from Molecular Probes, incubated with cells 30 minutes before determination. 20
Determination of Enzyme Activities
Protein tyrosine phosphatase (PTPase) activity was determined according to methods described in Reference 21. 21 Tyrosine kinase activity was evaluated as previously reported. 11
Statistical Analysis
Data are given as meanϮSEM. Estimates of statistical significance were performed by ANOVA (Student-Newman-Keuls multiple comparison test).
Chemicals and Biological Reagents
Antiphosphotyrosine (4G10) and anti-PDGF-AB antibodies were from UBI, monoclonal anti-PDGFR␤ from Transduction Laboratories, human PDGF-BB, anti-SHP2, anti-Grb2, anti-ERK1/ERK2, and polyclonal anti-PDGFR␤ from Santa Cruz, anti-Src, anti-Pserine from Calbiochem, anti-P-threonine from Chemicon, antiactivated MAPK from Promega, anti-4-HNE-protein polyclonal (K5 to 4412) from G. Jürgens Laboratory, 22 4-HNE from Tebu-Biomol, H2DCFDA and DHR from Molecular Probes, cell culture reagents from Gibco, and other chemicals from Sigma.
Results
MoxLDL Induces PDGFR␤ Tyrosine Phosphorylation in Cultured SMC Independent of Any Autocrine Effect
MoxLDL (at mitogenic concentration) elicited tyrosine phosphorylation of PDGFR␤, identified by immunoprecipitation and Western blot ( Figure 1 ). MoxLDL-induced PDGFR␤ tyrosine phosphorylation is sustained for 5 hours ( Figure 1A) , is dose-dependent (maximal PDGFR␤ tyrosine phosphorylation at 1 hour and 5 hours being obtained with 100 to 150 and 50 to 75 g apoB/mL, respectively) ( Figure 1B) , and is associated with the lipid fraction ( Figure 1C) .
Coimmunoprecipitation experiments showed that SH2containing relay proteins, such as Grb-2 (24 kDa), Src (60 kDa), and SHP2 (69 kDa), associated to PDGFR␤ phosphotyrosines ( Figure 1D ), thus demonstrating that UV-moxLDL or cell-moxLDL triggers effective activation of the PDGFR␤ signaling pathway. We prefered to use UV-moxLDL because cell-moxLDL preparations may contain potentially interfering bioactive compounds (released from ECV-304 cells).
A role for autocrine PDGF secretion was excluded because neutralizing anti-PDGF antibody (inhibiting PDGF-induced PDGFR␤ autophosphorylation) did not block the moxLDLinduced PDGFR␤ tyrosine phosphorylation ( Figure 1E ). Other autocrine mediators were also excluded by transfer of preconditioned medium on reporter cells ( Figure 1F ).
Mechanisms Implicated in moxLDL-Induced PDGFR␤ Activation
Antioxidants Inhibit the Late Phase of moxLDL-Induced PDGFR␤ Activation
The antioxidants BHT (100 mol/L) or catalase (1500 U/mL, permitting effective loading of SMC with catalase 23 ) were inactive in the first phase (1 hour) but strongly inhibited the second sustained phase (5 hours) of moxLDL-induced PDGFR␤ activation ( Figure 2 , A and B). In SMCcatϩ overexpressing catalase (by 350%), this second phase was abolished, in contrast to parental SMC ( Figure 2 , C and D). Altogether, the two phases are apparently mediated by two separate mechanisms, the first one involving an antioxidantinsensitive mechanism and the second one involving H 2 O 2 (catalase sensitive).
Oxidized Lipids and 4-HNE Induce Derivatization and Activation of PDGFR␤ MoxLDL (but not natLDL or PDGF) induces 4-HNE derivatization of PDGFR␤, as shown by evaluating [ 3 H]NSPreactive free amino groups of immunoprecipitated PDGFR␤ and 4-HNE-PDGFR␤ adducts (Figure 3, A and B) and by transfer of [ 3 H]4-HNE to PDGFR␤ (and other cell proteins)
coimmunoprecipitates of PDGFR␤ and SH2-containing proteins from SMC incubated with UV-moxLDL or cell-moxLDL (75 g/mL for 5 hours) (revelation by the indicated antibodies). E, Effect of neutralizing anti-PDGF antibody on PDGFR␤ tyrosine phosphorylation elicited by moxLDL (75 g apoB/mL) or PDGF (10 ng/mL, 20 minutes), with (ϩ) or without (Ϫ) neutralizing anti-PDGF antibody (25 g/mL). F, Transfer of preconditioned medium. SMC were pulsed for 1, 2, or 4 hours with moxLDL (75 g apoB/mL); after medium change, cells were "chased" in fresh basic (lipoprotein-and serum-free) medium for 1 hour. This preconditioned "chase" medium was transferred on and incubated with unstimulated "reporter" SMC for 1 hour. In control, SMC were incubated for 1 hour without (0) or with moxLDL. Figure 3C ). Chloroquine also inhibited moxLDL-induced PDGFR␤ activation ( Figure 3D ): In these experiments, cold and concanamycin A cannot be used because they induced per se PDGFR␤ autophosphorylation. Moreover, it may be noted that moxLDL elicited PDGFR␤ activation and MAPK activation in normal fibroblasts but no PDGFR␤ nor MAPK activation in LDL receptor-negative fibroblasts (data not shown). Altogether, these data suggest that a small part of moxLDL-associated 4-HNE derivatize PDGFR␤ through a chloroquine-sensitive process.
Consistently, incubation of SMC with 4-HNE induced 4-HNE-PDGFR␤ adduct formation, PDGFR␤ tyrosine phos- phorylation, and phosphotyrosine-binding SH2-protein recruitment ( Figure 3, A, B , and E). 4-HNE-induced PDGFR␤ activation was not associated with ROS generation and was antioxidant-insensitive ( Figure 3 , F and G), like the first phase of moxLDL-induced PDGFR␤ activation.
To investigate whether 4-HNE acts directly on PDGFR␤, we designed in vitro experiments with the use of immunopurified PDGFR␤. 4-HNE or moxLDL lipid extracts induced PDGFR␤ derivatization (decreased [ 3 H]NSP-reactive amino group content) and PDGFR␤ tyrosine phosphorylation, whereas lipid extracts of native LDL were inactive (Figure 3 , H and I). This suggests that 4-HNE and oxidized lipids mimic and may participate in the first (antioxidant-insensitive) phase of moxLDL-induced PDGFR␤ activation.
Second Antioxidant-Sensitive Phase of moxLDL-Induced PDGFR␤ Activation Is Mediated by Ceramide and H 2 O 2
The second phase (3 to 5 hours) of moxLDL-induced PDGFR␤ activation is catalase-sensitive, thus possibly mediated by H 2 O 2 . This hypothesis was compatible with moxLDL-induced ROS generation (fluorescence of oxidized DHR) ( Figure 4A ) and the inhibitory effect of BHT and catalase (under loading conditions 23 ). H 2 O 2 also triggered a strong PDGFR␤ autophosphorylation that was inhibited by BHT and catalase ( Figure 4B ).
Because moxLDL activates the sphingomyelin/ceramide pathway (ceramide peaking at 1 to 2 hours) in SMC 9 and ceramide induces H 2 O 2 generation, 24 we investigated the possible role of ceramide in moxLDL-induced H 2 O 2 generation and PDGFR␤ activation. Theoretically, ceramide may be generated through sphingomyelin hydrolysis either in LDL (by secretory sphingomyelinase) 25 or in cell membranes. 9 Smase-treated LDL did not trigger PDGFR␤ autophosphorylation ( Figure 4C ). In contrast, C2-ceramide and bacterial sphingomyelinase (generating ceramide at the plasma membrane 9 ) trigger ROS generation (consistent with data from Reference 24) 24 and PDGFR␤ autophosphorylation ( Figure  4D ). Interestingly, TPCK (tosylphenylalanylchloromethylketone), which blocks moxLDL-induced sphingomyelin/ceramide pathway activation, 9 also inhibited moxLDL-induced ROS generation and PDGFR␤ autophosphorylation ( Figure  4 , A and E). Altogether, these data suggest that the second antioxidant-sensitive phase of moxLDL-induced PDGFR␤ activation may be mediated (at least in part) by cellular ceramide and subsequent H 2 O 2 generation. A sustained PDGFR␤ tyrosine phosphorylation also may result from inhibition of regulatory mechanisms terminating PDGFR activation (namely PTPases and serine/threonine-phosphorylation of PDGFR). 26, 27 In moxLDL-treated SMC, a transient activation of PTPases was followed by inhibition (during the second phase of moxLDL-induced PDGFR activation), which was reversed by BHT. PDGF elicited activation of PTPases, which was inhibited by orthovanadate (a PTPase inhibitor) and H 2 O 2 , in agreement with data from Reference 26 ( Figure 5, A and B) .
Whereas PDGF triggered PDGFR␤ serine and threonine phosphorylation (serine phosphorylation being involved in terminating PDGFR␤ activation 27 ), incubation of SMC with moxLDL for 5 hours induced no PDGFR␤ serine phosphor-ylation ( Figure 5C ). Conversely, moxLDL incubated with cells for 1 hour and 5 hours did not downregulate PDGFR␤ kinase, in contrast to PDGF ( Figure 5D ). All these data suggest that the regulatory mechanisms terminating PDGFR␤ activation are inactive during the second phase of oxLDLinduced PDGFR␤ activation. Figure 3, A and B) . B, PDGFR␤ tyrosine phosphorylation induced by H 2 O 2 (500 mol/L) in the presence or absence of exogenous catalase (1500 U/mL) or BHT (100 mol/L). C and D, SMC were incubated with Smasetreated LDL (75 g apoB/mL, 5 hours) (C) or with C2-ceramide (10 mol/L) or Smase (25 mU/mL) (D). PDGFR␤ tyrosine phosphorylation was visualized on Western blots (as in Figure 1 ). E, Effect of TPCK (10 mol/L, 30 minutes of preincubation) on moxLDL-induced PDGFR␤ tyrosine phosphorylation (at 5 hours) (experimental conditions of Figure 5A ).
4-HNE Derivativatization Occurs in Rabbit Aortic Atherosclerosis
To check the relevance of the data reported above to in vivo atherosclerosis, 4-HNE-PDGFR␤ adduct formation was investigated in atherosclerotic rabbits. Cholesterol-fed rabbits exhibit hypercholesterolemia (25.10Ϯ3.46 g/L versus 1.04Ϯ0.10 g/L in normals) and large fatty streaks in thoracic aorta ( Figure 6A ). 4-HNE-PDGFR␤ adducts were clearly detected in atherosclerotic aorta (exhibiting extensive fatty streaks) but not in normal aorta (Figure 6B ).
Discussion
The data suggest that (1) PDGFR␤ is a target of moxLDL and is activated through two novel mechanisms involving oxidized lipids and ceramide/H 2 O 2 (Figure 7) ; and (2) moxLDL may be considered as a local autoparacrine mediator (generated in vascular wall and acting on neighboring cells).
4-HNE may constitute a first mediator of moxLDLinduced PDGFR␤ activation because 4-HNE evokes in vitro derivatization and tyrosine phosphorylation of immunopurified PDGFR␤ (the fine molecular mechanism, eg, conformational changes, linking both events remains to be elucidated). In intact living cells, 4-HNE-induced PDGFR␤ derivatization and activation is antioxidant-insensitive and independent of any ROS production, like the first phase of moxLDLinduced PDGFR␤ activation. HNE exists in two forms in oxLDL: (1) the major part is 4-HNE covalently bound to amino groups of proteins or phospholipids; (2) a minor part of 4-HNE remains free, is poorly diffusible toward the water environment, and is probably dissolved in the phospholipid phase of moxLDL because of its hydrophobicity. 4, 28 Experiments with [ 3 H]4-HNE-labeled moxLDL show that a small part of moxLDL-associated [ 3 H]4-HNE is transferred to PDGFR␤ (and other cell proteins). The mechanism of transfer of 4-HNE from moxLDL to PDGFR␤ is yet unknown. Diffusion of free 4-HNE from moxLDL toward PDGFR␤ through the culture medium is not probable because 4-HNE is hydrophobic (poorly diffusible) 28 and because [ 3 H]4-HNE trace amounts are rapidly scavenged by thiols (glutathione, cysteine) of culture medium (data not shown). Therefore, in moxLDL and during its transfer to PDGFR␤, free 4-HNE is probably prevented to react with thiols, hypothetically because of direct contact of moxLDL with PDGFR␤ or diffusion through a hydrophobic environment, such as membrane lipids. Finally, our data suggest that 4-HNE (and possibly other oxidized lipids) may play a role in the first antioxidantinsensitive phase of the moxLDL-induced PDGFR␤ activation.
The second antioxidant-sensitive phase (3 to 5 hours) of moxLDL-induced PDGFR␤ activation is mediated by ceramide and ROS. Cellular moxLDL-induced ceramide does not originate in LDL-associated ceramide but is generated through hydrolysis of cellular sphingomyelin (step blocked by TPCK). 9 The reported data suggest that moxLDL-induced ceramide 9 triggers ROS generation, which evokes PDGFR␤ activation: (1) TPCK, a nonantioxidant inhibitor of moxLDLinduced ceramide generation, 9 blocks ROS formation and PDGFR␤ activation; (2) C2-ceramide and ceramide generated by bacterial sphingomyelinase treatment triggers ROS generation, consistent with data from Reference 24, and PDGFR␤ activation; (3) BHT and catalase block both moxLDL-induced ROS formation and PDGFR␤ activation but not ceramide formation (data not shown); and (4) H 2 O 2 triggers PDGFR␤ activation (which is blocked by catalase and BHT).
It may be noted that although the fluorogenic oxidantsensitive probes detect various ROS, 20 H 2 O 2 is very probably the prominent ROS because increased catalase level (induced by cell loading 23 or overexpression) inhibited both moxLDLinduced ROS generation and the second phase of PDGFR␤ activation. This is consistent with the requirement of H 2 O 2 in PDGF signal transduction, 23 ROS-induced PDGFR␤ tyrosine-phosphorylation, 29 and ROS-induced SMC proliferation. 30 Moreover, moxLDL-induced inhibition of PTPases and serine phosphorylation of PDGFR␤ (two regulatory mechanisms involved in terminating PDGFR␤ activation) may be implicated in the second phase of moxLDL-induced PDGFR␤ activation. In agreement with data from Reference 26, this PTPase inhibition may be mediated by H 2 O 2 generated during the second phase of moxLDL-induced PDGFR␤ activation. BHT (which blocks H 2 O 2 generation) also prevented PTPase inhibition and the subsequent second phase of PDGFR␤ activation.
The reported data suggest that in atherosclerotic areas, PDGFR␤ can be activated by moxLDL, in addition to PDGF. However, in contrast to growth factors, moxLDL is a nonspecific mediator that triggers a broad spectrum of cellular signals. [5] [6] [7] [8] [9] [10] [11] For instance, moxLDL-induced PDGFR␤ activation is similar to that of EGFR, 12 thus extending the concept that moxLDL activates various tyrosine kinase receptors and suggesting that besides their classic role of transducers of growth factors signaling, PDGFR␤ and EGFR may act as cellular sensors for oxidative stress and oxidized lipids.
From a pathophysiological point of view, the presence of 4-HNE-PDGFR␤ adducts in atherosclerotic areas is direct evidence that oxidized lipids (originating from moxLDL or generated inside the cell during oxidative stress) may react in vivo with PDGFR␤, as in vitro and in cultured cells. Although tyrosine phosphorylation cannot be detected in aorta extracts (probably because of a rapid postmortem loss of phosphotyrosine in tissues), it may be speculated that oxidized lipids may interact with membrane tyrosine kinase receptors of vascular cells, thereby disturbing cellular responses such as migration, proliferation, and gene expression [13] [14] [15] and playing a role in intimal changes occurring during atherogenesis.
